SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12181827
Source:
http://linkedlifedata.com/resource/pubmed/id/12181827
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0023487
,
umls-concept:C0087111
,
umls-concept:C0205195
,
umls-concept:C0717668
pubmed:issue
7
pubmed:dateCreated
2002-8-16
pubmed:abstractText
To define duration and schemes of maintenance therapy, to evaluate cytarabine demand while treatment of acute promyelocytic leukemia (APL) with an original program 5D + Ifa + AT RA.
pubmed:language
rus
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/2984818R
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/Liposomes
,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion
,
http://linkedlifedata.com/resource/pubmed/chemical/Tretinoin
,
http://linkedlifedata.com/resource/pubmed/chemical/promyelocytic leukemia-retinoic...
pubmed:status
MEDLINE
pubmed:issn
0040-3660
pubmed:author
pubmed-author:DemidovaI AIA
,
pubmed-author:IsaevV GVG
,
pubmed-author:Ol'shanskaiaIu VIuV
,
pubmed-author:ParovichnikovaE NEN
,
pubmed-author:SavchenkoV GVG
,
pubmed-author:ShuravinaE NEN
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12181827-Adolescent
,
pubmed-meshheading:12181827-Adult
,
pubmed-meshheading:12181827-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:12181827-Bone Marrow
,
pubmed-meshheading:12181827-Daunorubicin
,
pubmed-meshheading:12181827-Drug Therapy, Combination
,
pubmed-meshheading:12181827-Female
,
pubmed-meshheading:12181827-Humans
,
pubmed-meshheading:12181827-Interferon-alpha
,
pubmed-meshheading:12181827-Leukemia, Promyelocytic, Acute
,
pubmed-meshheading:12181827-Liposomes
,
pubmed-meshheading:12181827-Male
,
pubmed-meshheading:12181827-Middle Aged
,
pubmed-meshheading:12181827-Neoplasm Proteins
,
pubmed-meshheading:12181827-Oncogene Proteins, Fusion
,
pubmed-meshheading:12181827-Pilot Projects
,
pubmed-meshheading:12181827-Polymerase Chain Reaction
,
pubmed-meshheading:12181827-Remission Induction
,
pubmed-meshheading:12181827-Tretinoin
pubmed:year
2002
pubmed:articleTitle
[Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia].
pubmed:publicationType
Journal Article
,
Clinical Trial
,
English Abstract